PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Northern Ontario School of Medicine Sudbury, ON, Canada.\', \'Northern Ontario School of Medicine Sudbury, ON, Canada; Health Sciences North Research Institute, Sudbury, ON, Canada.\', \'Northern Ontario School of Medicine Sudbury, ON, Canada; Canadian Addiction Treatment Centres, Markham, ON, Canada; ICES North, Sudbury, ON, Canada; Health Sciences North Research Institute, Sudbury, ON, Canada. Electronic address: dmarsh@nosm.ca.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0955-3959(20)30426-610.1016/j.drugpo.2020.103088
?:hasPublicationType
?:journal
  • The International journal on drug policy
is ?:pmid of
?:pmid
?:pmid
  • 33385974
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all